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ORIGINAL PAPERS
1. Serviço de Reumatologia, Hospital de Santa Maria – Centro Hospitalar
Universitário de Lisboa Norte, Centro Académico de Medicina de Lisboa 
2. Instituto Português de Reumatologia
3. Serviço de Reumatologia, Hospital CUF Descobertas 
4. Merck Sharp & Dome, since 2017 Novartis Farma and Centro de
Investigação em Saúde Pública, Escola Nacional de Saúde Pública,
Universidade NOVA de Lisboa
5. Roche 
6. AbbVie 
7. Pfizer 
8. IQVIA (IMS Health and Quintiles are now IQVIA) 
9. Associação Portuguesa de Profissionais de Saúde em
Reumatologia 
10. Liga Portuguesa Contra as Doenças Reumáticas 
11. Serviço de Reumatologia, Hospital Garcia de Orta
12. Unidade de Investigação em Reumatologia, Instituto de
Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa,
Centro Académico de Medicina de Lisboa 
13. Associação Portuguesa de Administradores Hospitalares:
Alexandre Lourenço; Associação Portuguesa de Profissionais de
cesses (11), and Outcomes (6). These indicators cover
eleven domains of quality of care: personnel and orga-
nizational structure, training and research, facilities,
equipment and information technology, budgeting and
financial resources, access to care, clinical records, pa-
tient communication, multidisciplinary management,
clinical outcomes, and patient and personnel satisfac-
tion. Decision on quality and excellence thresholds for
each of the 26 quality indicators was agreed upon a
consensus meeting gathering principal investigators of
the eight Rheumatology Departments that decided to
participate, task force core set members and invited
representatives of all Portuguese Departments/Units.
Rheumatoid arthritis was the chosen disease model of
the project based on the reliability of the outcomes to
be measured in the context of this condition. The se -
cond step was the assessment of the participating
Rheumatology Departments. During eighteen months,
research teams applied the 26 quality indicators to their
own Departments. The third step comprised data ana -
lysis and the elaboration of individual Rheumatology
Department reports and of a global public report.
Results: Eight Departments, comprising 80 specialists,
Saúde em Reumatologia: Lurdes Barbosa, Lurdes Narciso; Centro
Hospitalar Universitário do Algarve - Hospital de Faro: Célia Ribeiro,
Graça Sequeira, Lígia Silva; Centro Hospitalar do Baixo Vouga -
Hospital de Aveiro: Anabela Barcelos, Catarina Ambrósio, Renata
Aguiar; Centro Hospitalar Lisboa Ocidental - Hospital de Egas Moniz:
Fernando Pimentel dos Santos, Jaime Branco, João Gomes, Sofia
Serra, Teresa Pedrosa, Tiago Costa; Centro Hospitalar Universitário
de Lisboa Norte - Hospital de Santa Maria: Carla Macieira, JA Pereira
da Silva, José Carlos Romeu, Maria Inês Seixas; Centro Hospitalar
de São João - Hospital de São João: Maria Lúcia Costa, Miguel
Bernardes, Pedro Madureira; Centro Hospitalar Tondela-Viseu:
Maura Couto, Paulo Monteiro; Centro Hospitalar Cova da Beira -
Hospital Pêro da Covilhã: Margarida Oliveira; Hospital do Divino
Espírito Santo: Guilherme Figueiredo; Hospital Garcia de Orta:
Sandra Sousa; Hospital Ortopédico de Sant´Ana: Filipe Araújo;
Instituto Português de Reumatologia: Augusto Faustino, Luís
Cunha Miranda; Unidade Local de Saúde Alto Minho: Daniela Faria,
Filipa Teixeira, Maria do Carmo Afonso; Unidade Local de Saúde
Guarda: Cláudia Vaz; Unidade Local de Saúde de Castelo Branco:
Pedro Abreu
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AbstrAct 
Background: Quality of care is a key component of the
right to health, and the route to equity and dignity. The
aim of the project Rheuma SPACE - Standard Practice
Aiming Clinical Excellence was to develop a set of qual-
ity indicators focused in rheumatoid arthritis care and
apply them to rheumatology departments of the Por-
tuguese National Health Service in order to benchmark
the care for these patients. This article details the
methodology that was applied.
Methodology: This was a single country, three-phase
project, each phase comprising multiple steps. The first
step defined quality indicators and the excellence qual-
ity model to be used. It involved a literature search for
international benchmarking of quality of care initia-
tives and indicators, followed by a pre-selection of an
initial set of indicators. The set of indicators was latter
on narrowed after an online Delphi round with all Por-
tuguese rheumatologists and two consensus meetings
involving the study task force. A set of 26 quality indi-
cators was defined, within the three classic Donabe dian
dimensions of healthcare quality: Structure (9), Pro-
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20 residents and 30 nurses, covering 5.904.080 in-
habitants, underwent quality evaluation. More than
one thousand patients (1.325) and 113 health profes-
sionals’ surveys were analysed, as well as data from
570 clinical records and 3.927 medical appointments
on rheumatoid arthritis patients. 
Discussion: 26 quality indicators were used for 
the first evaluation of Portuguese Rheumatology 
Departments, turning Rheuma SPACE into a pioneer
project. Data analysis and benchmarking will be the
subject of a further publication.
Keywords: Quality of Care; Quality Indicators.
introduction 
Health care professionals and stakeholders are in-
creasingly faced with scientific and technological 
advances, leading to constant and frequent changes in
clinical practice. To ensure that the progress in medical
science represents an effective contribution for high stan-
dards of care, assessment of the Quality of Care is an in-
dispensable additional tool1. Quality of Care is a key
component of the right to health, and the route to equi-
ty and dignity. In order to achieve this, health care must
be safe, effective, timely, efficient, equitable and people-
centred2. In addition, quality of care evaluation is the
only way to ensure that the programmed measures are
being effective in achieving the proposed outcomes.
In the specific field of Rheumatology evaluating the
practice of day care units/infusion rooms has been the
main line of work, pioneering quality of care in diffe -
rent clinical settings3-5. The Spanish Society of
Rheumatology published an interesting project almost
exclusively focused on day care units/infusion rooms.
They started by implementing a cross-sectional char-
acterization of existing shortcomings and then evolved
into the application of a model of excellence, the
“Reumatolex Project”6. Finally, they established the in-
dicators and other management tools to ensure a pa-
tient-oriented practice, based on both evidence and
clinical experience6,7, considering stakeholders’ opin-
ions and patients’ perspectives. Two other publications
explored, under the same perspective, disease course
monitoring8 and patients’ satisfaction9. Alternative 
approaches to quality assessment in the field of
rheuma tic diseases have characterized general aspects
of global care in rheumatic diseases10-13 or have applied
measures of quality for specific diseases, such as juve-
nile idiopathic arthritis14 or lupus15. In the case of
rheumatoid arthritis (RA) healthcare quality indicators
and standards of care for this disease have been draft-
ed across Europe, mainly focusing on disease activity
and outcomes16-22.
An additional concern in the context of quality of
care implementation and evaluation is the balanced
involvement of patients as they are now perceived as
active recipients of care, welcoming equal dialogue
with health care staff23,24. 
The Portuguese Society of Rheumatology (SPR) em-
braced quality as a major goal and launched in early
2015, a program to aim at excellence in global clinical
care: Rheuma SPACE - Standard Practice Aiming Clin-
ical Excellence25, 26. This program envisages improving
the performance of Portuguese Rheumatology De-
partments focused on RA care, involving a multi-stake-
holder approach with patients playing an active and
important role. RA was chosen as the disease model
due to the comprehensive set of quality indicators al-
ready proposed in the literature and for being a rela-
tively homogenous disease that facilitate the process
of quality of care assessment. 
The main purpose of Rheuma SPACE was to devel-
op a set of quality indicators focused in RA care and ap-
ply them to rheumatology departments of the Nation-
al Health Service in order to benchmark the care for
these patients. Herein we describe the methodology fol-
lowed to develop the evaluating tool of this program.
Methods
Rheuma SPACE was initially thought as a three-phase
project:
1. Establishing a set of quality indicators and an ex-
cellence quality model focused on RA care. The se-
lection of quality indicators was done in 2015. 
2. Assessment of the current care at Rheumatology De-
partments using the defined quality indicators. This
fieldwork was performed over 2015 and 2016.
3. Elaboration of global and customized reports for
each participating Rheumatology Department. This
data analysis phase was done over 2016 and 2017.
Each of these three phases comprised multiple steps.
PhAse 1: defining quAlity indicAtors And
An excellence quAlity Model
STEP 1: PROJECT’S TEAM
Rheuma SPACE project started by participants’ selec-
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tor IQVIA always assured total data anonymity and
confidentiality (PLu, JS).fn1
• Partners: they’ve collaborated in all Rheuma SPACE’
phases as team partners of the task force, assuring
that other health care stakeholders’ perspectives
were taken into consideration. Representatives of
the following organizations were involved in the pro-
ject: Portuguese Association of Hospital Managers,
nurses from the Portuguese Rheumatology Health
Care Professionals Association (LN, LB), patients’ re -
presentatives from the Portuguese League against
Rheumatic Diseases (EM)fn2. Also relevant to the pro-
ject was the work already done by the eumusc.net
project21,22 supported by the European Union and
European League against Rheumatism. A represen-
tative of this project gave feedback regularly during
the development of Rheuma Spacefn3.
• Participants: a total of ten Rheumatology Depart-
ments belonging to the National Health Service,
country-wide, including large and smaller centres,
were invited to participate in the project. One De-
partment was unable to allocate time and resources
to participate and another one failed to complete all
project phases. At the end, eight Departments were
evaluated.
STEP 2: SELECTION OF QUALITy INDICATORS
The definition of quality indicators of care provided by
tion and defining a project team:
• Promotor: SPR was responsible for the project lea -
dership, methodology definition and technical co-
ordination.
• Task force: a) a central core of five rheumatologists,
including the SPR president (JEF) and the SPR presi -
dent elect (JCS), two rheumatology specialists from
two large Rheumatology Departments (CM, LCM)
and one specialist with former experience of wor -
king in a medium size Rheumatology Department
(PN); b) rheumatologists representing smaller cen-
tres who collaborated in selected parts of the project
(Rheuma SPACE study group); c) other professio -
nals, including a rheumatologist MD (MB), pharm D
(SF,IF) and an epidemiologist (PL) working at the
medical departments of four pharmaceutical com-
panies also gave an important and original input at
different phases of the project.fn1
• Enablers: AbbVie, Merck Sharp & Dome, Pfizer and
Roche, gave the necessary budgetary support.
• Executor: IQVIA (IMS Health and Quintiles are now
IQVIA) was the executor agent, responsible for
methodological executive support in all participa -
ting centres, organization details and data keeping
analysis and synthesis, and finally, elaboration of a
global and customized Department reports. Execu-
tAble i. euroPeAn quAlity AssessMent benchMArks
Rheumatology standards of care, quality guidelines and indicators initiatives
eumusc.net eumusc.net aims to harmonize quality of care of rheumatic diseases across Europe and defined 
14 quality indicators
DANBIO In Denmark the patient registry is used to evaluate quality according to 7 clinical processes and 
outcomes - related criteria
Le Point Le Point’s Hospitals and Clinics’ ranking aims to support patient’s selection of healthcare units based
on their quality
DRFZ The German rheumatologic database has been gathering information since 1993 to evaluate care in
Rheumatology
DREAM The DREAM collaboration is an established patient registry used to benchmark hospitals on 
rheumatoid arthritis care outcomes and efficiency
ÍCARO The Spanish Rheumatology Society has work on quality of care evaluation since 2006 focusing on
Hospital’s day care practice, resulting in several publications
NICE NICE defined 7 quality statements for rheumatoid arthritis, across different stages of patient pathway
fn1. JEF- João Eurico Fonseca, JCS- José Canas da Silva, CM- Carla
Macieira, LCM- Luís Cunha Miranda, PN- Patrícia Nero, MB- Mónica
Bogas, SF- Sara Farinha, IF- Isabel Freitas, PL- Pedro Laires, 
PLu- Pedro Lucas, JS- Joana Sousa
fn2. LN-Lurdes Narciso, LB-Lurdes Barbosa, EM-Elsa Mateus
fn3. AW-Anthony Wolf
fn4. TM-Tolero Molina, RGV-Rosario Garcia de Vicuña
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Rheumatology Departments, along with a model of ex-
cellence was settled over four sub-steps.
Sub-step 2.1: literature search
The task force performed an extensive process of lite -
rature search for international publications on rheuma-
tology standards of care, quality guidelines and indi-
cators. However, the publications on this subject were
scarce. Table I summarizes the work developed by
some Rheumatology Societies in Europe. Of note, the
Spanish Rheumatology Society, over the last two
decades, developed and published data centred on 
hospital’s day care practice6-7. Specific indicators for
RA16,18-20 patients’ care have been detailed16,18-22, but ju-
venile idiopathic arthritis14 and lupus’15 quality of care
indicators were also found.
Sub-step 2.2: stakeholders’ interviews
At the same time, the characteristics of the patients
flowing within Rheumatology Departments were
mapped. Interviews with doctors, nurses and hospital
managers at several institutions took place. The opi -
nion and feedback of several stakeholders was valuable
and considered. A preliminary list of Rheumatology
care related topics was gathered, compiled and trans-
lated into quality indicators, each one measurable and
pertinent to the Portuguese reality. Globally, 412 dif-
ferent indicators were collected throughout this pro-
ject phase. At the end of this stage, interviews with in-
ternational key opinion leaders were made to gather
additional expertise from previous experiencesfn4.
Sub-step 2.3: quality indicators selection
The 412 collected indicators were organized according
to the Donabedian framework27 comprising three di-
mensions: structure - resources and administration, pro-
cess - culture and professional cooperation, and out-
comes – competence development and goal
achievement. 
This was structured in 3 major questions:
Structure – how well equipped are Rheumatology
Departments in terms of personnel, training and re-
search, facilities, equipment and information systems,
budgeting and financial resources?
Process – how is care provided to rheumatic patients
in terms of access to care and productivity, medical care
and clinical records, physician-patient communication
and multidisciplinary patient management?
Outcomes – what results have been achieved across
stakeholders in terms of outcomes, patient and per-
sonnel satisfaction?
These three dimensions aggregate twelve domains
of healthcare quality (Table II).
Starting from the 412 selected items, 2 crucial out-
comes had to be obtained:
• Indicators selection
• Quality/excellence definition
In order to obtain a concise list of quality indicators
for Rheumatology care, the team proceeded with a four-
stage RAND-modified Delphi28 approach (Figure 1).
figure 1. Four-stage RAND-modified Delphi methodology
used to identify and select quality indicators
tAble ii. donAbediAn’s diMensions And
doMAins
Dimensions Domain
Structure Personnel and organizational structure
Training and research
Facilities, equipment and information
systems
Structure budgeting and financial
resources
Process Access to care and productivity
Medical care and clinical records
Physician - patient communication
Multidisciplinary patient management
Outcomes Clinical outcomes
Patient satisfaction
Personnel satisfaction
Therapeutic costs and care efficiency
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RAND-modified Delphi approach
Stage 1 and 2: literature search and task force 
pre-selection
Items from the preliminary list (412 indicators) were
pre-selected by the task force over the course of two
meetings. Before the first meeting, task force members
gave their individual scores to each indicator based on
plausibility, applicability and their individual expe -
rience. Individual work was compiled by IQVIA and
discussed in the first meeting, with a focus on criteria
for which the range of relevance was higher (least con-
sensual items). All indicators were further re-evaluat-
ed in a second meeting, resulting in a shorter list of 87
items.
Stage 3: online 1st Delphi round – all rheumatologists
Since its start, the project aimed to be inclusive and to
incorporate the view of most SPR members. An online
Delphi questionnaire tool was designed and shared
with all rheumatologists. SPR members with an email
address registered (146 rheumatology experts) were in-
vited to participate in the Delphi questionnaire round.
They were asked to rate all indicators in a Likert scale
(from 1 - not important at all, up to 9 - crucial). To en-
sure a proper prioritization a benchmark indicator was
defined, one for each Donabedian dimension of quali-
ty. Indicators were grouped into these three categories
and received a classification for their relevance in com-
parison to the benchmark. Fifty rheumatologists gave
complete scores in the Delphi questionnaire round - a
34% response rate. Eighty-seven indicators were vo -
ted, and after the online Delphi meeting output, 57
moved on to a second selection round.
Stage 4: consensus meeting 2nd Delphi round - expert
panel
A second consensus meeting was required to obtain a
smaller set of indicators to be used, to agree on the in-
clusion of the highest scored indicator, exclusion of the
lowest ones and at the end, the determination of the fi-
nal list of quality indicators. The panel included the
task force, eight department directors, a patient repre-
sentative, two members of the Rheumatology Health
Care Professionals Association and the head of the in-
ternational project eumusc.net21, 22, who shared his ex-
perience and best practicesfn3. Experts were required to
vote for the exclusion of indicators within each of the
twelve domains of quality of care, discussed the results
of the voting, had a second voting round after the dis-
cussion and collectively agree on the final set to be in-
cluded in the project’s list. Some indicators were
grouped together, rephrased or further detailed. A final
set of 26 quality indicators that reflected the quality of
care envisioned for the Portuguese Rheumatology was
reached.
Sub step 2.4: quality indicators thresholds 
definition - quality/excellence
A measurement scale and quality/excellence thresholds
were developed for each of the 26 selected quality in-
dicators and again the Delphi method was used. Pub-
lished evidence was valuable but scarce and Delphi
provided a good starting point for some indicators. De-
cision on quality and excellence thresholds was agreed
at a second consensus meeting gathering principal in-
vestigators of the eight Rheumatology Departments,
task force members and representatives from all Por-
tuguese Departments/Units.
PhAse 2: AssessMent of rheuMAtology 
dePArtMents
Ten Rheumatology Departments country-wide, large
and smaller institutions were asked to participate in
Rheuma SPACE to ensure national coverage.
Departments were asked to set up a research team
including one to three rheumatologists and residents –
Rheuma SPACE study group, that assured data access
and collection. All clinical data needed was obtained
from Reuma.pt, the Rheumatic Diseases Portuguese
Register. No face-to-face interviews were performed. 
Quality indicators measurement required significant
team effort in the use of different data sources:
1. Department opinion: the team was asked to evalua -
te current practices and resources and adapt the 
application of some criteria in accordance to local
rea lity
2. Clinical records from RA patients: data was obtained
from Reuma.pt in order to minimize “perception”
bias and guarantee methodology uniformity
3. Surveys: questionnaires were applied to both pa-
tients and staff, inquiring about their satisfaction
with current practices and other topics
4. Research teams were asked to collect inputs related
to administrative procedures, equipment and other
structural Department standards
PhAse 3: dAtA AnAlysis, globAl And 
individuAl rheuMAtology dePArtMent 
rePorts
At the end of a twelve months collection phase,
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Rheuma SPACE executor IQVIA proceeded with con-
fidential data analysis, resulting in a report for each De-
partment along with global benchmarking practices
analysis.
Results were first presented and discussed with each
research team, and afterwards with each involved De-
partments. Final individual reports for each centre were
developed, identifying positive aspects, best practices
and improvement areas. On October 2016, at a meet-
ing promoted by SPR, national results were presented
and discussed.
Furthermore, the development of a list of improve-
ment initiatives seemed crucial to ensure benefits from
Rheuma SPACE and initiating a future process of defin-
ing key macro objectives and milestones. Two task force
meetings took place. A three-step methodology aim-
ing to identify and prioritize potential improvement
initiatives was presented:
STEP 1: ITEMS SELECTION AND BRAINSTORMING
• Task force agreement on what quality indicators to
focus on
• Listing down all potential ideas to tackle selected is-
sues
STEP 2: DESCRIPTION AND ORGANIzATION
• Production of a short description statement for each
selected idea
• Aggregation of groups of ideas according to agreed
criteria into similarity clusters
STEP 3: PRIORITIzATION
• Discussion of each initiative’s impact, as well as the
implementation challenges
• Prioritizing and mapping improvement initiatives in
a “wish timeline”
A list of potential initiatives was selected to be dis-
cussed as an improvement quality plan for each De-
partment.
ETHIC ISSUES
Authorization from Administration Boards and Ethics
Committees was obtained from the participating Hos-
pitals. All clinical data needed was obtained from
Reuma.pt, the Rheumatic Diseases Portuguese Register.
A signed informed consent for participating in clinical
research was collected from patients participating at the
register. Reuma.pt is approved by all local ethics com-
mittees and the national board for the protection of per-
sonal data (Comissão Nacional de Proteção de dados)29.
results 
PhAse 1: defining quAlity indicAtors And An
excellence quAlity Model
With the four-step RAND-modified Delphi approach a
final list of 26 quality indicators was obtained - nine
structure, eleven processes and six outcomes indica-
tors, from eleven domains of quality of care (Table III).
The expert panel unanimously agreed at a consensus
meeting, on the exclusion of therapeutic costs and care
efficiency indicators.
At the end of Rheuma SPACE phase 1, task force
members prepared individual indicators discussion at
a second consensus meeting. As a result, quality and ex-
cellence thresholds were additionally defined (Table
IV).
PhAse 2: AssessMent of rheuMAtology 
dePArtMents
In the beginning of Rheuma SPACE phase 2 - assess-
ment of Rheumatology Departments - eight of the 10
invited Departments accepted to participate and com-
pleted the evaluation process (Table V).
These eight Departments, comprising 80 specialists,
20 residents and 30 nurses, covering 5.904.080 in-
habitants, underwent quality evaluation.
More than one thousand patients (1.325) and 113
health professionals’ surveys were analysed, as well as
data from 570 clinical records and 3.927 medical ap-
pointments. This information is listed in Table III:
Rheuma Space final criteria list and concerns the Pro-
cess Dimension in “Medical care and clinical records,
criteria 13-16” and the Outcomes Dimension in “Clini -
cal outcomes, criteria 21-23”.
PhAse 3: dAtA AnAlysis, globAl And 
individuAl rheuMAtology dePArtMent 
rePorts
This information will be released in a separate publi-
cation addressing the outcome of the Rheuma SPACE
project.
discussion
Selection of quality indicators based on both published
evidence and experience of several stakeholders offered
guidelines for comparing quality standards. These 26
indicators were used for the first quality evaluation of
Portuguese Rheumatology Departments, turning
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tAble iii. rheuMA sPAce 26 quAlity indicAtors 
STRUCTURE – How equipped are Rheumatology Departments?
Personnel and 1. Number of rheumatologists per population covered
organizational 2. Number of nurses dedicated to Rheumatology per population covered
structure 3. Existence and frequency of medical audits assessing the compliance with guidelines that are
accepted by Rheumatology
Training and 4. Existence and implementation of an annual training plan for healthcare professionals, 
research including monthly clinical sessions for continued scientific training 
5. Percentage of rheumatologists' time dedicated to research and audit
Facilities, 6. Access to medical and informatics technology equipment (ultrasonography, polarized light 
equipment and microscope, capillaroscopy instrument, densitometer, and computers with internet access)
information systems 7. Existence of a patient electronic medical record (EMR) with data protection systems and its
availability across Rheumatology Departments’ to healthcare professionals 
8. Physical access (distance, physical barriers and orientation boards/signs) to hospital and to
different services related to Rheumatology care, particularly to patients with disabilities
Structure budgeting 9. Annual implementation of an internal contract between Department and Administration, 
and financial including budget and activity planning, quality indicators and funds for research & training
resources
PROCESSES – How is care provided to rheumatic patients?
Access to care 10. Patient triage is performed by a rheumatologist, according to criteria defined by
and productivity Rheumatology
11. Percentage of patients who get a first appointment in Rheumatology within due waiting time,
according to prioritization criteria established by Rheumatology 
12. Percentage of patients with disease flares or potential drug related side effects that received
advice within 1 working day of contacting the service
Medical care and 13. Frequency of follow up appointments - rheumatoid arthritis as a case study
clinical records 14. Frequency of assessment of pain, disease activity, patient function, quality of life and 
co-morbidities - rheumatoid arthritis as a case study
15. Frequency of pharmacological therapy review for all Rheumatology specific medication, 
including toxicity monitoring in a patient with active disease - rheumatoid arthritis as a case
study
16. Percentage of patients with a frequently updated record on REUMA.PT with a set of minimum
criteria - rheumatoid arthritis as a case study
Patient 17. Percentage of patients who were given educational materials regarding the disease and/or 
communication treatment
18. Percentage of patients followed in a day hospital or Rheumatology techniques unit who were
given a direct telephone access of the Rheumatology Department healthcare professional
Multidisciplinary 19. Ability to provide a multidisciplinary approach according to patients' needs
patient management 20. Percentage of diagnosed patients given a written communication addressing their general
practitioner or other relevant health care provider, explaining the clinical situation and 
including the contact of the rheumatologist
OUTCOMES – What results have been achieved across stakeholders?
Clinical outcomes 21. Percentage of rheumatoid arthritis patients with significant improvement in disease activity,
disability and quality of life (according to international validated criteria), after 6 months of
treatment
continues on the next page
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tAble iii. continuAtion
22. Number of absent days per rheumatologic patient, per year - rheumatoid arthritis as a case
study
23. Percentage of rheumatology patients that were granted early retirement due to illness – 
rheumatoid arthritis as a case study
Patient satisfaction 24. Patient overall satisfaction with Rheumatology care
25. Patient satisfaction with service facilities (consultations and waiting room, privacy, toilets,
etc.)
Personnel 26. Healthcare professionals' overall satisfaction with Department environment, team work and 
satisfaction cooperation within Department professionals
tAble iv. quAlity And excellence threshold definitions for structure, Processes And outcoMes
quAlity indicAtors
Domain Indicator Quality threshold Excellence threshold
STRUCTURE
Personnel and 1. Number of Rheumatologists per 1 Rheumatologist per 1 Rheumatologist per
organizational population covered ≤ 60.000 and > 40.000 ≤ 40.000 inhabitants
structure 2. Number of nurses dedicated to inhabitants 1 nurse per ≤ 120.000  
Rheumatology service per population covered 1 nurse per ≤ 240.000 inhabitants
3. Existence and frequency of medical audits and > 120.000 
assessing the compliance with those guidelines inhabitants
that are accepted by Rheumatology ≥ 50%* and < 85%* ≥ 85%*
Training and 4. Existence and implementation of an annual ≥ 50%* and < 85%* ≥ 85%
research training plan for healthcare professionals, 
including monthly clinical sessions for 
continued scientific training
5. Percentage of Rheumatologists' time dedicated ≥ 10% and < 20% ≥ 20%
to research and audit
Facilities, 6. Access to medical and IT equipment ≥ 60%* and < 85%* ≥ 85%*
equipment and (ultrasonography, polarized light microscope, 
information capillaroscopy instrument, densitometer, and
systems computers with internet access)
7. Existence of a patient electronic medical ≥ 50%* and < 85%* ≥ 85%*
record (EMR) with data protection systems and 
its availability across Rheumatology services to 
healthcare professionals
8. Physical access (distance, physical barriers ≥ 60%* and <90%* ≥ 90%*
and orientation boards/signs) to hospital and to 
different services related to Rheumatology care, 
particularly to patients with disabilities 
Structure 9. Annual implementation of an internal ≥ 50%* and < 85%* ≥ 85%*
budgeting and contract between Service and Administration,
financial including budget and activity planning, quality
resources indicators and funds for research and training 
continues on the next page
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tAble iv. continuAtion
Domain Indicator Quality threshold Excellence threshold
PROCESSES
Access to care 10. Patient triage is performed by a ≥ 60%* and < 80%* ≥ 85%*
and productivity rheumatologist, according to criteria defined 
by Rheumatology
11. Percentage of patients who get a first ≥ 80% and <90% ≥ 90%
appointment in Rheumatology within due 
waiting time, according to prioritization criteria 
established by Rheumatology
11.1. High Priority (1st appointment within 
30 days)
11.2. Priority (1st appointment within 90 days)
11.3. Normal Priority (1st appointment within 
180 days)
12. Percentage of patients with disease flares or ≥ 85% and <95% ≥ 95%
potential drug related side effects that received 
advice within one working day of contacting 
the service
Medical care and 13. Frequency of follow up appointments 
clinical records (rheumatoid arthritis as a case study)
13.1. Active disease (DAS28 ≥3.2) ≤ 10 and > 6 weeks ≤ 6 weeks
13.2. In Remission (DAS28 <2.6) ≤ 16 and > 12 weeks ≤ 12 weeks
13.3. Under Biologic Therapy ≤ 10 and > 6 weeks ≤ 6 weeks
13.4. No Biologic Therapy ≤ 16 and > 12 weeks ≤ 12 weeks
14. Frequency of assessment of pain, disease 
activity, patient function, quality of life and co-
-morbidities (rheumatoid arthritis as a case study)
14.1. Active disease (DAS28 ≥3.2) ≤ 10 and > 6 weeks ≤ 6 weeks
14.2. In Remission (DAS28 <2,6) ≤ 16 and > 12 weeks ≤ 12 weeks
15. Frequency of pharmacological therapy review ≤ 9,5 and > 6 weeks ≤ 6 weeks
for all Rheumatology specific medication, 
including toxicity monitoring in a patient with 
active disease (rheumatoid arthritis as a case study)
 16. Percentage of patients with a frequently ≥ 60% and < 80% ≥ 80%
updated record on REUMA.PT with a set of 
minimum criteria (rheumatoid arthritis as a 
case study)
Patient 17. Percentage of patients who were given 
communication educational materials regarding the disease 
and/or treatment
17.1. Biologic Therapy ≥ 80% and < 95% ≥ 95%
17.2. No Biologic Therapy ≥ 50% and < 80% ≥ 80%
18. Percentage of patients followed in a day ≥ 80% and < 95% ≥ 95%
hospital or Rheumatology techniques unit who 
were given a direct telephone access of the 
Rheumatology service healthcare professional
continues on the next page
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tAble iv. continuAtion
Domain Indicator Quality threshold Excellence threshold
Multidisciplinary 19. Ability to provide a multidisciplinary ≥ 50%* and < 75%* ≥ 75%*
patient approach according to patients' needs
management 20. Percentage of diagnosed patients given a ≥ 80% and < 95% ≥ 95%
written communication addressing their GP or 
other relevant HCP, explaining the clinical 
situation and including the contact of the 
rheumatologist
20.1. Patients perspective
20.2. Physicians perspective
OUTCOMES
Clinical 21. Percentage of rheumatoid arthritis patients ≥ 60% and >80% ≥ 80%
outcomes with significant improvement in disease activity, 
disability and quality of life (according to 
international validated criteria), after 6 months 
of treatment
22. Number of absent days per rheumatologic ≤ 15 and >7 days ≤ 7 days
patient, per year, from patients' perspective
23. Percentage of rheumatology patients that ≤ 20% and >10% ≤ 10%
were granted early retirement due to illness
Patient 24. Patients overall satisfaction with ≥ 70%* and < 90%* ≥ 90%*
satisfaction Rheumatology care
25. Patients satisfaction with service facilities ≥ 70%* and < 90%* ≥ 90%*
(consultations and waiting room, privacy, toilets, 
etc.) 
Personnel 26. Healthcare professionals' overall satisfaction ≥ 70%* and < 90%* ≥ 90%*
satisfaction with Department environment, team work and 
cooperation within Department professionals
*Composite score from an ad hoc instrument developed specifically for project SPACE
tAble v. rheuMA sPAce PArticiPAting Portuguese dePArtMents
Department Status
Unidade Local de Saúde Alto Minho Completed data collection
Centro Hospitalar Universitário - Hospital de São João Completed data collection
Centro Hospitalar Tondela Viseu Completed data collection
Centro Hospitalar Universitário de Lisboa Norte - Hospital de Santa Maria Completed data collection
Centro Hospitalar de Lisboa Ocidental - Hospital de Egas Moniz Completed data collection
Instituto Português de Reumatologia Completed data collection
Hospital Garcia de Orta Completed data collection
Centro Hospitalar e Universitário do Algarve - Hospital de Faro Completed data collection
Centro Hospitalar do Baixo Vouga - Hospital de Aveiro Could not collect data
Centro Hospitalar Universitário de Coimbra Choose not to participate
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Rheuma SPACE into a pioneer project. 
Rheuma SPACE methodology was designed on a
RAND-modified Delphi approach based on literature
evidence, but also expert and stakeholders’ opinions,
online Delphi rounds and consensus meetings open to
all SPR members. We believe that the work developed
resulted in solid indicators that went further beyond
the previous evaluations of the practice of day care units
previous done across Europe3,5-7,16. In addition, it was
an inclusive collaborative work: eight Departments,
comprising 80 specialists, 20 residents and 30 nurses,
covering 5.904.080 inhabitants.
This project allowed an in deep analysis of quality in-
dicators adapted to the Portuguese reality, paving the
way for subsequent studies. In addition, the field phase
of the project enrolled local teams that became aware
of the relevance of quality of care and motivated to fur-
ther monitor it. Finally, this project set the seeds for
benchmarking the quality of care of Rheumatology
practice in Portugal.
The Rheuma SPACE project has some limitations. In
line with previous studies16-22, 30, we have chosen RA as
a clinical model, though it may not represent the stan-
dard of care for all rheumatic patients. The 26 indica-
tors have been developed based on evidence that have
been published, reviewed by experts’ panels and proved
to be applicable to the Portuguese reality. However, they
lack an independent validation, as well as, an external
proof of reliability and feasibility. In addition, effective
improvement initiatives may also turn hard to conduct. 
conclusions
The number of rheumatologists, patients, allied pro-
fessionals, management personnel as well as the task
force member’s expertise, ensured a representative and
solid view on the Standard of Practise Aiming for Clini -
cal Excellence quality indicators. Improving quality of
care is a continuous and resilient effort. Future stake-
holders’ partnerships may enhance and facilitate the
development and implementation of selected im-
provement strategies as in other projects aiming at
Quality of Care31. 
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